Capital Insight Partners, LLC Novartis Ag Transaction History
Capital Insight Partners, LLC
- $568 Million
- Q1 2025
A detailed history of Capital Insight Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Capital Insight Partners, LLC holds 30,832 shares of NVS stock, worth $3.62 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
30,832
Previous 29,669
3.92%
Holding current value
$3.62 Million
Previous $2.89 Million
19.05%
% of portfolio
0.61%
Previous 0.5%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.39 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.22 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1.01 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$829 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$795 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $253B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...